Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-21
1996-01-09
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546276, A61K 3144
Patent
active
054829534
ABSTRACT:
The invention relates to 2,4- and 2,5-bistetrazolylpyridines. Said compounds inhibit the enzymes proline hydroxylase and lysine hydroxylase and bring about a selective inhibition of collagen biosynthesis. They are used as fibrosuppressants and immunosuppressants.
REFERENCES:
patent: 4717727 (1988-01-01), Gunzler et al.
patent: 4968670 (1990-11-01), Brocks et al.
patent: 5013736 (1991-05-01), Nagahara et al.
patent: 5037839 (1991-08-01), Bickel et al.
Wade . Organic Chemistry . Prentice-Hall. New Jersey 1987. p. 349.
Suarez et al. Heterocyclic Chem. 15. 1093-1096 1978.
Zeffren et al. The Study of Enzyme Mechanism p. 87. 1974.
Haring, M., et al., Helvetica Chemica Acta, 37(17):147-153 (1954).
Itai, T., et al., Bulletin National Institute of Hygiene, 74:115-117 (1956).
Shinohara, et al., Chemistry High Polymers, Japan, 15:839-849 (1958).
Hirakata, T. et al., J. Pharm. Soc. Japan, 77:219-221 (1957).
Majamaa, K. et al., Eur. J. Biochem, 138:239-245 (1984).
Tschank, G. et al., Biochem. J., 248:625-633 (1987).
Baader Ekkehard
Bickel Martin
Gunzler-Pukall Volkmar
Schubert Gerrit
Fan Jane
Hoechst Aktiengesellschaft
LandOfFree
2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303340